ImageneBio, Inc.
IMA
$5.84
-$0.03-0.51%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -100.00% | -100.00% | -77.14% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -100.00% | -100.00% | -77.14% | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -100.00% | -100.00% | -77.14% | -- | -- |
| SG&A Expenses | 223.75% | 176.95% | 147.00% | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 128.26% | 119.39% | 21.61% | -- | -- |
| Operating Income | -173.84% | -165.27% | -30.95% | -- | -- |
| Income Before Tax | -143.98% | -147.22% | -25.01% | -- | -- |
| Income Tax Expenses | -2,592.31% | -2,715.38% | -2,792.31% | -- | -- |
| Earnings from Continuing Operations | -142.34% | -145.39% | -24.01% | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -142.34% | -145.39% | -24.01% | -- | -- |
| EBIT | -173.84% | -165.27% | -30.95% | -- | -- |
| EBITDA | -172.30% | -169.99% | -33.99% | -- | -- |
| EPS Basic | 45.77% | -118.14% | -65,580.00% | -- | -- |
| Normalized Basic EPS | 21.94% | -174.45% | -82,055.38% | -- | -- |
| EPS Diluted | 45.77% | -118.14% | -65,580.00% | -- | -- |
| Normalized Diluted EPS | 21.94% | -174.45% | -82,055.38% | -- | -- |
| Average Basic Shares Outstanding | -89.35% | -92.25% | -94.12% | -- | -- |
| Average Diluted Shares Outstanding | -89.35% | -92.25% | -94.12% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |